In millions, except per share items | Mar-31-20 | Dec-31-19 | Sep-30-19 | Jun-30-19 | Mar-31-19 | Dec-31-18 | Sep-30-18 | Jun-30-18 |
| 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
Net income | -136.3 | -3.3 | -11.7 | -1.4 | -2.0 | 2.3 | -3.9 | 0.6 |
Depreciation and amortization | 8.7 | 9.1 | 9.5 | 10.1 | 9.6 | 9.5 | 9.2 | 9.6 |
Asset impairment charges | 64.2 | | 7.2 | | | | 2.1 | |
Stock-based compensation | 1.1 | 0.8 | 0.9 | 0.8 | 1.1 | 0.6 | 0.6 | 0.6 |
Deferred taxes | | | | | | -0.3 | 0.1 | -0.1 |
Change in working capital [+] | -1.5 | -2.5 | 0.8 | 0.4 | 2.2 | -1.3 | 0.4 | 0.9 |
Accounts receivable | 1.2 | 0.5 | -0.3 | 0.0 | -0.2 | -0.1 | -0.2 | -0.2 |
Other current assets | -0.3 | 1.0 | -1.5 | 1.8 | -0.3 | 0.4 | -3.9 | 2.3 |
Other | -2.3 | -4.0 | 2.6 | -1.4 | 2.7 | -1.6 | 4.4 | -1.1 |
Other operating activities | 72.0 | -0.5 | -0.4 | -4.4 | 4.5 | 5.6 | -3.7 | 1.1 |
Cash from operations | 8.3 | 3.5 | 6.2 | 5.5 | 15.4 | 16.3 | 4.7 | 12.7 |
|
Capital expenditures [+] | -5.5 | -4.4 | -4.2 | -3.7 | -3.9 | -3.5 | -3.9 | -3.0 |
Purchases of property and equipment | -5.5 | -4.4 | -4.2 | -3.7 | -3.9 | 0.5 | -3.9 | -3.0 |
Capitalized product costs | | | | | | -4.0 | | |
Acquisitions | | | | | -21.7 | -12.3 | -11.7 | -7.3 |
Other cash from investing | | | | | | 0.0 | 0.1 | |
Cash from investing | -5.5 | -4.4 | -4.2 | -3.7 | -25.5 | -15.7 | -15.5 | -10.2 |
|
Cash dividends paid | | | | | | | 0.0 | |
Option exercises | | 0.0 | | | 0.0 | 0.0 | 0.0 | 0.0 |
Financing costs | | | | | | -0.2 | | |
Other cash from financing | 3.2 | -1.0 | -10.9 | -9.1 | -0.8 | -1.1 | 2.5 | 1.7 |
Cash from financing | 3.2 | -1.0 | -10.9 | -9.1 | -0.8 | -0.9 | 2.4 | 1.7 |
|
Free cash flow | 2.7 | -0.9 | 2.0 | 1.7 | 11.5 | 16.9 | 0.9 | 9.8 |
Per share (diluted) | $0.10 | ($0.03) | $0.08 | $0.07 | $0.44 | $0.49 | $0.03 | $0.37 |
|
Cash paid for interest | 2.6 | 2.7 | 3.9 | 2.1 | 3.1 | 3.4 | 2.9 | 3.0 |
Cash paid for income taxes | 0.0 | -0.1 | 0.0 | 0.1 | 0.0 | 13.1 | 0.0 | 0.5 |